$BPMC Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Blueprint Medicines Corp.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Blueprint Medicines Corp. Get notifications about new insider transactions in Blueprint Medicines Corp for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 30 2017 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 49.10 | 2,229 | 109,444 | 35,486 | 37.7 K to 35.5 K (-5.91 %) |
Jun 30 2017 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 50.22 | 10,205 | 512,495 | 37,715 | 47.9 K to 37.7 K (-21.30 %) |
Jun 30 2017 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 51.21 | 7,566 | 387,455 | 47,920 | 55.5 K to 47.9 K (-13.64 %) |
Jun 30 2017 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Business Offi ... | Option Exercise | M | 16.28 | 6,357 | 103,492 | 120,929 | |
Jun 30 2017 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Business Offi ... | Sell | S | 50.00 | 6,357 | 317,850 | 0 | 6.4 K to 0 (-100.00 %) |
Jun 30 2017 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Business Offi ... | Buy | M | 16.28 | 6,357 | 103,492 | 6,357 | 0 to 6.4 K |
Jun 23 2017 | BPMC | Blueprint Medicine ... | Borisy Alexis | Director | Option Exercise | A | 46.02 | 10,909 | 502,032 | 21,818 | |
Jun 23 2017 | BPMC | Blueprint Medicine ... | Demetri George | Director | Option Exercise | A | 46.02 | 10,909 | 502,032 | 57,271 | |
Jun 23 2017 | BPMC | Blueprint Medicine ... | Lydon Nicholas | Director | Option Exercise | A | 46.02 | 10,909 | 502,032 | 21,818 | |
Jun 23 2017 | BPMC | Blueprint Medicine ... | LYNCH DANIEL | Director | Option Exercise | A | 46.02 | 10,909 | 502,032 | 21,818 | |
Jun 23 2017 | BPMC | Blueprint Medicine ... | Goldberg Mark Alan | Director | Option Exercise | A | 46.02 | 10,909 | 502,032 | 43,636 | |
Jun 23 2017 | BPMC | Blueprint Medicine ... | COATS LONNEL | Director | Option Exercise | A | 46.02 | 10,909 | 502,032 | 43,636 | |
Jun 23 2017 | BPMC | Blueprint Medicine ... | Seely Lynn | Director | Option Exercise | A | 46.02 | 10,909 | 502,032 | 43,636 | |
Jun 23 2017 | BPMC | Blueprint Medicine ... | Rowland Charles A Jr | Director | Option Exercise | A | 46.02 | 10,909 | 502,032 | 43,636 | |
Mar 20 2017 | BPMC | Blueprint Medicine ... | LEVIN MARK J | 10% Owner | Sell | S | 41.55 | 5,200 | 216,060 | 111,244 | 116.4 K to 111.2 K (-4.47 %) |
Mar 20 2017 | BPMC | Blueprint Medicine ... | LEVIN MARK J | 10% Owner | Sell | S | 40.74 | 24,800 | 1,010,352 | 116,444 | 141.2 K to 116.4 K (-17.56 %) |
Mar 16 2017 | BPMC | Blueprint Medicine ... | Lydon Nicholas | Director | Sell | S | 39.72 | 1,400 | 55,608 | 202,727 | 204.1 K to 202.7 K (-0.69 %) |
Mar 16 2017 | BPMC | Blueprint Medicine ... | Lydon Nicholas | Director | Sell | S | 40.06 | 68,600 | 2,748,116 | 204,127 | 272.7 K to 204.1 K (-25.15 %) |
Mar 16 2017 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Business Offi ... | Option Exercise | M | 16.28 | 12,714 | 206,984 | 87,286 | |
Mar 16 2017 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Business Offi ... | Sell | S | 40.01 | 12,714 | 508,687 | 0 | 12.7 K to 0 (-100.00 %) |
Mar 16 2017 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Business Offi ... | Buy | M | 16.28 | 12,714 | 206,984 | 12,714 | 0 to 12.7 K |
Mar 16 2017 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 39.75 | 980 | 38,955 | 55,486 | 56.5 K to 55.5 K (-1.74 %) |
Mar 16 2017 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 40.04 | 19,020 | 761,561 | 56,466 | 75.5 K to 56.5 K (-25.20 %) |
Mar 16 2017 | BPMC | Blueprint Medicine ... | LYNCH DANIEL | Director | Sell | S | 40.12 | 7,500 | 300,900 | 250,119 | 257.6 K to 250.1 K (-2.91 %) |
Feb 21 2017 | BPMC | Blueprint Medicine ... | McCain Tracey L | EVP and Chief Legal ... | Option Exercise | A | 36.05 | 5,000 | 180,250 | 105,000 | |
Feb 21 2017 | BPMC | Blueprint Medicine ... | Landsittel Michael | PFO and PAO | Option Exercise | A | 36.05 | 20,000 | 721,000 | 58,181 | |
Feb 21 2017 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Business Offi ... | Option Exercise | A | 36.05 | 40,000 | 1,442,000 | 140,000 | |
Feb 21 2017 | BPMC | Blueprint Medicine ... | Boral Anthony L. | Chief Medical Offic ... | Option Exercise | A | 36.05 | 45,000 | 1,622,250 | 189,544 | |
Feb 09 2017 | BPMC | Blueprint Medicine ... | Third Rock Ventures II, L.P. | 10% Owner | Sell | S | 35.28 | 1,000,000 | 35,275,000 | 4,453,753 | 5.5 M to 4.5 M (-18.34 %) |
Dec 21 2016 | BPMC | Blueprint Medicine ... | STARR KEVIN P | 10% Owner | Sell | S | 28.19 | 106,489 | 3,002,351 | 0 | 106.5 K to 0 (-100.00 %) |
Dec 05 2016 | BPMC | Blueprint Medicine ... | LYNCH DANIEL | Director | Sell | S | 30.02 | 200 | 6,004 | 255,694 | 255.9 K to 255.7 K (-0.08 %) |
Nov 23 2016 | BPMC | Blueprint Medicine ... | Dorsch Marion | Chief Scientific Of ... | Option Exercise | A | 37.11 | 110,000 | 4,082,100 | 110,000 | |
Nov 03 2016 | BPMC | Blueprint Medicine ... | LYNCH DANIEL | Director | Sell | S | 30.04 | 1,700 | 51,068 | 255,894 | 257.6 K to 255.9 K (-0.66 %) |
Oct 17 2016 | BPMC | Blueprint Medicine ... | LYNCH DANIEL | Director | Sell | S | 30.02 | 21,800 | 654,436 | 257,594 | 279.4 K to 257.6 K (-7.80 %) |
Oct 04 2016 | BPMC | Blueprint Medicine ... | McCain Tracey L | EVP and Chief Legal ... | Option Exercise | A | 28.36 | 100,000 | 2,836,000 | 100,000 | |
Aug 10 2016 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 23.22 | 1,008 | 23,406 | 75,486 | 76.5 K to 75.5 K (-1.32 %) |
Aug 10 2016 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 23.22 | 1,008 | 23,406 | 75,486 | 76.5 K to 75.5 K (-1.32 %) |
Aug 10 2016 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 22.84 | 15,992 | 365,257 | 76,494 | 92.5 K to 76.5 K (-17.29 %) |
Aug 10 2016 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 22.84 | 15,992 | 365,257 | 76,494 | 92.5 K to 76.5 K (-17.29 %) |
Jun 27 2016 | BPMC | Blueprint Medicine ... | Seely Lynn | Director | Option Exercise | A | 19.53 | 10,909 | 213,053 | 32,727 | |
Jun 27 2016 | BPMC | Blueprint Medicine ... | COATS LONNEL | Director | Option Exercise | A | 19.53 | 10,909 | 213,053 | 32,727 | |
Jun 27 2016 | BPMC | Blueprint Medicine ... | Rowland Charles A Jr | Director | Option Exercise | A | 19.53 | 10,909 | 213,053 | 32,727 | |
Jun 27 2016 | BPMC | Blueprint Medicine ... | LYNCH DANIEL | Director | Option Exercise | A | 19.53 | 10,909 | 213,053 | 10,909 | |
Jun 27 2016 | BPMC | Blueprint Medicine ... | Lydon Nicholas | Director | Option Exercise | A | 19.53 | 10,909 | 213,053 | 10,909 | |
Jun 27 2016 | BPMC | Blueprint Medicine ... | Goldberg Mark Alan | Director | Option Exercise | A | 19.53 | 10,909 | 213,053 | 32,727 | |
Jun 27 2016 | BPMC | Blueprint Medicine ... | Demetri George | Director | Option Exercise | A | 19.53 | 10,909 | 213,053 | 46,362 | |
Jun 27 2016 | BPMC | Blueprint Medicine ... | Borisy Alexis | Director | Option Exercise | A | 19.53 | 10,909 | 213,053 | 10,909 | |
Jun 07 2016 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 20.03 | 17,000 | 340,510 | 92,486 | 109.5 K to 92.5 K (-15.53 %) |
Mar 28 2016 | BPMC | Blueprint Medicine ... | Lengauer Christoph | Chief Scientific Of ... | Option Exercise | M | 1.87 | 6,668 | 12,469 | 134,316 | |
Mar 28 2016 | BPMC | Blueprint Medicine ... | Lengauer Christoph | Chief Scientific Of ... | Option Exercise | M | 1.49 | 12,499 | 18,561 | 140,984 | |
Mar 28 2016 | BPMC | Blueprint Medicine ... | Lengauer Christoph | Chief Scientific Of ... | Buy | M | 1.87 | 6,668 | 12,469 | 91,382 | 84.7 K to 91.4 K (+7.87 %) |
Mar 28 2016 | BPMC | Blueprint Medicine ... | Lengauer Christoph | Chief Scientific Of ... | Buy | M | 1.49 | 12,499 | 18,561 | 84,714 | 72.2 K to 84.7 K (+17.31 %) |
Feb 05 2016 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Option Exercise | A | 15.01 | 140,000 | 2,101,400 | 679,548 | |
Feb 05 2016 | BPMC | Blueprint Medicine ... | Lengauer Christoph | Chief Scientific Of ... | Option Exercise | A | 15.01 | 40,000 | 600,400 | 178,179 | |
Feb 05 2016 | BPMC | Blueprint Medicine ... | Boral Anthony L. | Chief Medical Offic ... | Option Exercise | A | 15.01 | 40,000 | 600,400 | 144,544 | |
Feb 05 2016 | BPMC | Blueprint Medicine ... | Landsittel Michael | PFO and PAO | Option Exercise | A | 15.01 | 10,000 | 150,100 | 38,181 | |
Feb 05 2016 | BPMC | Blueprint Medicine ... | COATS LONNEL | Director | Option Exercise | A | 15.01 | 21,818 | 327,488 | 21,818 | |
Apr 15 2016 | BPMC | Blueprint Medicine ... | Seely Lynn | Director | Option Exercise | A | 19.08 | 21,818 | 416,287 | 21,818 | |
Apr 15 2016 | BPMC | Blueprint Medicine ... | Third Rock Ventures II, L.P. | 10% Owner | Sell | J | 0.00 | 1,200,000 | 0 | 5,453,753 | 6.7 M to 5.5 M (-18.03 %) |
Apr 14 2016 | BPMC | Blueprint Medicine ... | Lengauer Christoph | Chief Scientific Of ... | Sell | S | 20.01 | 15,872 | 317,599 | 56,657 | 72.5 K to 56.7 K (-21.88 %) |
Apr 13 2016 | BPMC | Blueprint Medicine ... | Lengauer Christoph | Chief Scientific Of ... | Sell | S | 20.01 | 10,316 | 206,423 | 72,529 | 82.8 K to 72.5 K (-12.45 %) |
Apr 13 2016 | BPMC | Blueprint Medicine ... | Lengauer Christoph | Chief Scientific Of ... | Sell | S | 20.30 | 8,537 | 173,301 | 82,845 | 91.4 K to 82.8 K (-9.34 %) |
Apr 08 2016 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 20.42 | 17,000 | 347,140 | 109,486 | 126.5 K to 109.5 K (-13.44 %) |
Feb 02 2016 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Business Offi ... | Option Exercise | A | 16.28 | 100,000 | 1,628,000 | 100,000 | |
Dec 17 2015 | BPMC | Blueprint Medicine ... | Lengauer Christoph | Chief Scientific Of ... | Sell | S | 25.14 | 6,463 | 162,480 | 72,215 | 78.7 K to 72.2 K (-8.21 %) |
Dec 17 2015 | BPMC | Blueprint Medicine ... | Lengauer Christoph | Chief Scientific Of ... | Sell | S | 25.03 | 24,156 | 604,625 | 78,678 | 102.8 K to 78.7 K (-23.49 %) |
Dec 17 2015 | BPMC | Blueprint Medicine ... | Lengauer Christoph | Chief Scientific Of ... | Sell | S | 25.00 | 500 | 12,500 | 102,834 | 103.3 K to 102.8 K (-0.48 %) |
Dec 02 2015 | BPMC | Blueprint Medicine ... | LYNCH DANIEL | Director | Buy | J | 0.00 | 2,517 | 0 | 275,244 | 272.7 K to 275.2 K (+0.92 %) |
Dec 02 2015 | BPMC | Blueprint Medicine ... | Borisy Alexis | Director | Buy | J | 0.00 | 8,561 | 0 | 26,742 | 18.2 K to 26.7 K (+47.09 %) |
Nov 30 2015 | BPMC | Blueprint Medicine ... | FMR LLC | Sell | S | 21.97 | 55,419 | 1,217,555 | 264,898 | 320.3 K to 264.9 K (-17.30 %) | |
Nov 30 2015 | BPMC | Blueprint Medicine ... | FMR LLC | Sell | S | 21.86 | 2,400 | 52,464 | 320,317 | 322.7 K to 320.3 K (-0.74 %) | |
Nov 30 2015 | BPMC | Blueprint Medicine ... | FMR LLC | Sell | S | 21.48 | 174,096 | 3,739,582 | 322,717 | 496.8 K to 322.7 K (-35.04 %) | |
Nov 30 2015 | BPMC | Blueprint Medicine ... | FMR LLC | Sell | S | 20.97 | 55,500 | 1,163,835 | 496,813 | 552.3 K to 496.8 K (-10.05 %) | |
Nov 25 2015 | BPMC | Blueprint Medicine ... | FMR LLC | 10% Owner | Sell | S | 20.14 | 161,271 | 3,247,998 | 552,313 | 713.6 K to 552.3 K (-22.60 %) |
Nov 23 2015 | BPMC | Blueprint Medicine ... | FMR LLC | 10% Owner | Sell | S | 20.22 | 61,600 | 1,245,552 | 713,584 | 775.2 K to 713.6 K (-7.95 %) |
Nov 23 2015 | BPMC | Blueprint Medicine ... | FMR LLC | 10% Owner | Sell | S | 20.05 | 23,700 | 475,185 | 775,184 | 798.9 K to 775.2 K (-2.97 %) |
Nov 23 2015 | BPMC | Blueprint Medicine ... | FMR LLC | 10% Owner | Sell | S | 20.17 | 81,272 | 1,639,256 | 798,884 | 880.2 K to 798.9 K (-9.23 %) |
Nov 23 2015 | BPMC | Blueprint Medicine ... | FMR LLC | 10% Owner | Sell | S | 20.02 | 23,000 | 460,460 | 880,156 | 903.2 K to 880.2 K (-2.55 %) |
Nov 20 2015 | BPMC | Blueprint Medicine ... | FMR LLC | 10% Owner | Sell | S | 19.79 | 131,044 | 2,593,361 | 903,156 | 1 M to 903.2 K (-12.67 %) |
Nov 20 2015 | BPMC | Blueprint Medicine ... | FMR LLC | 10% Owner | Sell | S | 19.93 | 24,850 | 495,261 | 1,034,200 | 1.1 M to 1 M (-2.35 %) |
Nov 20 2015 | BPMC | Blueprint Medicine ... | FMR LLC | 10% Owner | Sell | S | 19.69 | 76,024 | 1,496,913 | 1,059,050 | 1.1 M to 1.1 M (-6.70 %) |
Nov 20 2015 | BPMC | Blueprint Medicine ... | FMR LLC | 10% Owner | Sell | S | 20.19 | 100 | 2,019 | 1,135,074 | 1.1 M to 1.1 M (-0.01 %) |
Nov 20 2015 | BPMC | Blueprint Medicine ... | FMR LLC | 10% Owner | Sell | S | 19.41 | 5,200 | 100,932 | 1,135,174 | 1.1 M to 1.1 M (-0.46 %) |
Nov 19 2015 | BPMC | Blueprint Medicine ... | FMR LLC | 10% Owner | Sell | S | 20.20 | 464 | 9,373 | 1,140,374 | 1.1 M to 1.1 M (-0.04 %) |
Nov 19 2015 | BPMC | Blueprint Medicine ... | FMR LLC | 10% Owner | Sell | S | 21.07 | 8,509 | 179,285 | 1,140,838 | 1.1 M to 1.1 M (-0.74 %) |
Nov 19 2015 | BPMC | Blueprint Medicine ... | FMR LLC | 10% Owner | Sell | S | 20.31 | 14,717 | 298,902 | 1,149,347 | 1.2 M to 1.1 M (-1.26 %) |
Nov 19 2015 | BPMC | Blueprint Medicine ... | FMR LLC | 10% Owner | Sell | S | 20.70 | 3,800 | 78,660 | 1,164,064 | 1.2 M to 1.2 M (-0.33 %) |
Nov 19 2015 | BPMC | Blueprint Medicine ... | FMR LLC | 10% Owner | Gift | G | 0.00 | 733 | 0 | 1,167,864 | 1.2 M to 1.2 M (-0.06 %) |
Nov 18 2015 | BPMC | Blueprint Medicine ... | Third Rock Ventures II, L.P. | 10% Owner | Buy | J | 0.00 | 40,290 | 0 | 40,290 | 0 to 40.3 K |
Nov 18 2015 | BPMC | Blueprint Medicine ... | Third Rock Ventures II, L.P. | 10% Owner | Buy | J | 0.00 | 40,290 | 0 | 40,290 | 0 to 40.3 K |
Nov 18 2015 | BPMC | Blueprint Medicine ... | Third Rock Ventures II, L.P. | 10% Owner | Buy | J | 0.00 | 40,290 | 0 | 40,290 | 0 to 40.3 K |
Nov 18 2015 | BPMC | Blueprint Medicine ... | Third Rock Ventures II, L.P. | 10% Owner | Sell | J | 0.00 | 220,387 | 0 | 0 | 220.4 K to 0 (-100.00 %) |
Nov 18 2015 | BPMC | Blueprint Medicine ... | Third Rock Ventures II, L.P. | 10% Owner | Buy | J | 0.00 | 220,387 | 0 | 220,387 | 0 to 220.4 K |
Nov 18 2015 | BPMC | Blueprint Medicine ... | Third Rock Ventures II, L.P. | 10% Owner | Sell | J | 0.00 | 739,306 | 0 | 6,653,753 | 7.4 M to 6.7 M (-10.00 %) |
Nov 18 2015 | BPMC | Blueprint Medicine ... | FMR LLC | 10% Owner | Sell | S | 20.77 | 2,779 | 57,720 | 1,168,597 | 1.2 M to 1.2 M (-0.24 %) |
Nov 18 2015 | BPMC | Blueprint Medicine ... | FMR LLC | 10% Owner | Sell | S | 22.02 | 300 | 6,606 | 1,171,376 | 1.2 M to 1.2 M (-0.03 %) |
Nov 18 2015 | BPMC | Blueprint Medicine ... | FMR LLC | 10% Owner | Sell | S | 21.41 | 1,820 | 38,966 | 1,171,676 | 1.2 M to 1.2 M (-0.16 %) |
Nov 18 2015 | BPMC | Blueprint Medicine ... | FMR LLC | 10% Owner | Sell | S | 20.78 | 23,785 | 494,252 | 1,173,496 | 1.2 M to 1.2 M (-1.99 %) |
Nov 17 2015 | BPMC | Blueprint Medicine ... | FMR LLC | 10% Owner | Gift | G | 0.00 | 25,955 | 0 | 1,197,281 | 1.2 M to 1.2 M (-2.12 %) |
Nov 17 2015 | BPMC | Blueprint Medicine ... | FMR LLC | 10% Owner | Gift | G | 0.00 | 4,567 | 0 | 1,223,236 | 1.2 M to 1.2 M (-0.37 %) |
Nov 17 2015 | BPMC | Blueprint Medicine ... | FMR LLC | 10% Owner | Gift | G | 0.00 | 68,628 | 0 | 1,227,803 | 1.3 M to 1.2 M (-5.29 %) |
Nov 17 2015 | BPMC | Blueprint Medicine ... | FMR LLC | 10% Owner | Sell | J | 0.00 | 1,204,280 | 0 | 1,296,431 | 2.5 M to 1.3 M (-48.16 %) |
Nov 12 2015 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 21.87 | 7,000 | 153,090 | 126,486 | 133.5 K to 126.5 K (-5.24 %) |
Nov 04 2015 | BPMC | Blueprint Medicine ... | Lengauer Christoph | Chief Scientific Of ... | Sell | S | 20.98 | 36,734 | 770,679 | 103,334 | 140.1 K to 103.3 K (-26.23 %) |
Nov 04 2015 | BPMC | Blueprint Medicine ... | Lengauer Christoph | Chief Scientific Of ... | Sell | S | 21.10 | 48,264 | 1,018,370 | 140,068 | 188.3 K to 140.1 K (-25.63 %) |
Nov 04 2015 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 21.02 | 10,000 | 210,200 | 133,486 | 143.5 K to 133.5 K (-6.97 %) |
May 12 2015 | BPMC | Blueprint Medicine ... | Third Rock Ventures II, L.P. | 10% Owner | Option Exercise | C | 0.00 | 1,328,502 | 0 | 0 | |
May 12 2015 | BPMC | Blueprint Medicine ... | Third Rock Ventures II, L.P. | 10% Owner | Option Exercise | C | 0.00 | 7,833,333 | 0 | 0 | |
May 12 2015 | BPMC | Blueprint Medicine ... | Third Rock Ventures II, L.P. | 10% Owner | Option Exercise | C | 0.00 | 30,000,000 | 0 | 0 | |
May 12 2015 | BPMC | Blueprint Medicine ... | Third Rock Ventures II, L.P. | 10% Owner | Buy | C | 0.00 | 241,545 | 0 | 7,393,059 | 7.2 M to 7.4 M (+3.38 %) |
May 12 2015 | BPMC | Blueprint Medicine ... | Third Rock Ventures II, L.P. | 10% Owner | Buy | C | 0.00 | 1,424,242 | 0 | 7,151,514 | 5.7 M to 7.2 M (+24.87 %) |
May 12 2015 | BPMC | Blueprint Medicine ... | Third Rock Ventures II, L.P. | 10% Owner | Buy | C | 0.00 | 5,454,545 | 0 | 5,727,272 | 272.7 K to 5.7 M (+2,000.00 %) |
May 07 2015 | BPMC | Blueprint Medicine ... | FMR LLC | 10% Owner | Option Exercise | C | 0.00 | 483,092 | 0 | 0 | |
May 07 2015 | BPMC | Blueprint Medicine ... | FMR LLC | 10% Owner | Option Exercise | C | 0.00 | 2,583,333 | 0 | 0 | |
May 07 2015 | BPMC | Blueprint Medicine ... | FMR LLC | 10% Owner | Option Exercise | C | 0.00 | 10,000,000 | 0 | 0 | |
May 07 2015 | BPMC | Blueprint Medicine ... | FMR LLC | 10% Owner | Buy | P | 18.00 | 125,000 | 2,250,000 | 2,500,711 | 2.4 M to 2.5 M (+5.26 %) |
May 07 2015 | BPMC | Blueprint Medicine ... | FMR LLC | 10% Owner | Buy | C | 0.00 | 87,834 | 0 | 2,375,711 | 2.3 M to 2.4 M (+3.84 %) |
May 07 2015 | BPMC | Blueprint Medicine ... | FMR LLC | 10% Owner | Buy | C | 0.00 | 469,696 | 0 | 2,287,877 | 1.8 M to 2.3 M (+25.83 %) |
May 07 2015 | BPMC | Blueprint Medicine ... | FMR LLC | 10% Owner | Buy | C | 0.00 | 1,818,181 | 0 | 1,818,181 | 0 to 1.8 M |